💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cogentix Medical, Inc. (CGNT)
« Back to company indexCGNT Chatter Timeline
Stock Ticker for CGNT
Most Active Tweeters for CGNT
| User | Tweets |
|---|---|
| @InsiderForms | 3 |
| @DanielAlGu1 | 1 |
| @ValueNotDeadYet | 1 |
| @stock_titan | 1 |
| @BiotechBandit1 | 1 |
Recent Tweets for CGNT
 |
@BiotechBandit1 @Keubiko They should look at $cgnt May 15th 2021, 12:05pm |
 |
@InsiderForms RGM Capital LLC,has filed Form 13F for Q1 2021.Opened NEW positions in $CGNT $GWRE Try Insider Forms mobile app, g… https://t.co/RLXMc4Qy9z May 14th 2021, 6:05pm |
|
@InsiderForms Neumeier Poma Investment Counsel LLC,has filed Form 13F for Q1 2021.Opened NEW positions in $CGNT $MODV Try Inside… https://t.co/jjVIC03yXV May 12th 2021, 12:05pm |
 |
@stock_titan $CGNT Cognyte Announces Participation in Upcoming Investor Conferences https://t.co/WPqrBqkkid May 12th 2021, 12:05pm |
|
@InsiderForms WESTPORT ASSET MANAGEMENT INC,has filed Form 13F for Q1 2021.Opened NEW positions in $CGNT $ORCL Try Insider Forms… https://t.co/l8XCkN1mtt May 11th 2021, 6:05pm |
 |
@ValueNotDeadYet @CRyanSchadel $CGNT is worth a look if you like $PLTR, decent IR presentation on their website. May 11th 2021, 1:05pm |
 |
@DanielAlGu1 many new investor groups opening a position in $cgnt It won't take long to be noticed by the majority. It is impo… https://t.co/tRknxUW5VR May 7th 2021, 9:05pm |
 |
@SiteFocusHQ $CGNT Earnings Intelligence Analysis of recent earnings identified Cognyte Software Ltd. (CGNT) business focus on (… https://t.co/qBzoTLEJJp May 1st 2021, 10:05pm |
 |
@SeekingAlpha $CGNT - Cognyte Software Ltd. (CGNT) CEO Elad Sharon on Q4 2020 Results - Earnings Call Transcript.… https://t.co/i4HSrtasZU May 1st 2021, 9:05pm |
 |
@newsfilterio Cognyte Software Announces Q4 and Fiscal Year Ended January 31, 2021 Results $CGNT https://t.co/FHobD0r4Dx May 1st 2021, 10:05am |
 |
@ResearchPool $CGNT #Cognyte Software Ltd. Solid First Quarter Out of the Gates; Undervalued Growth Story Set to Play Out: [...]… https://t.co/dr3bQsQv6A April 30th 2021, 11:04am |
 |
@EdgarInsider New Form 6-K entry filed by $CGNT Cognyte Software Ltd https://t.co/sWw4TnQrZI April 29th 2021, 10:04pm |
 |
@Briefingcom $CGNT: Cognyte Software beats by $0.13, reports revs in-line; guides Q1 EPS above consensus, revs above consensus;.… https://t.co/G8xyIfngyb April 29th 2021, 3:04pm |
|
@DanielAlGu1 Less and less overlooked. Promising future $cgnt April 29th 2021, 2:04pm |
 |
@Patiwak Glad I have been adding to $CGNT, great first print. https://t.co/pCyP1OxTR9 April 29th 2021, 1:04pm |
|
@newsfilterio Cognyte Software EPS beats by $0.13, beats on revenue $CGNT https://t.co/LtGkrtp66s April 29th 2021, 12:04pm |
 |
@glitchbotio RT @MarketCurrents: $CGNT - Cognyte Software EPS beats by $0.13, beats on revenue https://t.co/io85vr23UX April 29th 2021, 12:04pm |
 |
@MarketCurrents $CGNT - Cognyte Software EPS beats by $0.13, beats on revenue https://t.co/io85vr23UX April 29th 2021, 12:04pm |
 |
@otcdynamics $CGNT Cognyte Software Announces Q4 and Fiscal Year Ended January 31, 2021 Results https://t.co/i8J0VEy9NE April 29th 2021, 12:04pm |
|
@stock_titan $CGNT Cognyte Software Announces Q4 and Fiscal Year Ended January 31, 2021 Results https://t.co/JX71MYq9mr April 29th 2021, 12:04pm |
 |
@StockPods $CGNT Earnings Call Today: 8:30 AM EST Webcast: https://t.co/pgq3wvNMjh Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 April 29th 2021, 11:04am |
 |
@AccesswireNews $CGNT Cognyte Software Ltd to Host Earnings Call https://t.co/hfetZqGQFE April 29th 2021, 10:04am |
 |
@cylex_x eyeing $CGNT calls to play their earnings tmrw. complete yolo play, barely any dd... ? April 28th 2021, 10:04am |
|
@otcdynamics $CGNT Cognyte to Announce Fourth Quarter and Full Year Ending January 31, 2021 Financial Results on Thursday, April… https://t.co/gJroxxcJlX April 26th 2021, 6:04pm |
 |
@FlashAlert_me $CGNT [15s. delayed]: Issued Press Release on April 26, 14:11:00: Cognyte to Announce Fourth Quarter and Full Year… https://t.co/2G6yGHFxcs April 26th 2021, 6:04pm |
|
@stock_titan $CGNT Cognyte to Announce Fourth Quarter and Full Year Ending January 31, 2021 Financial Results on Thursday, April… https://t.co/sUMXQQCZQh April 26th 2021, 6:04pm |
|
@DanielAlGu1 @BuffaloBillCo @MiamiValue Do you like palantir? Well, check $cgnt It may surprise you. Greetings (I follow you on Twitter) April 26th 2021, 8:04am |
 |
@AlertTrade REVERSALtoUP: $CGNT Cognyte Software Ltd. Ordinary Shares https://t.co/7a1pZDNGeu ? TradeIdeas via ? https://t.co/VS8RO0TZ6b April 23rd 2021, 6:04pm |
|
@DanielAlGu1 Today we buy $cgnt.The idea was revealed to us by Mr. F. Sánchez and after reading the reports of a member of our c… https://t.co/tq3UWo68hG April 13th 2021, 2:04pm |
 |
@Tickeron A.I.dvisor is predicting $CGNT is about to fall. View odds of downtrend. #CognyteSoftware #stockmarket #stock… https://t.co/Nv90sspjR3 April 11th 2021, 8:04am |
 |
@NesteggMcMuffin @Patiwak Ditto. Nice entry price right now, but $CGNT earnings this month will change that. April 8th 2021, 2:04pm |
|
@Patiwak Took a starter in the Verint spinoff Cognyte $CGNT under $27. With a current P/S ratio of 4 (based on Verint finan… https://t.co/EVQinNht4n April 5th 2021, 11:04pm |
 |
@ChartMill $CGNT has one of the better Altman-Z scores in its industry: 101.27 vs 4.25. https://t.co/4jBPrmRdWP https://t.co/KrEWIAHU4Y April 2nd 2021, 6:04pm |
|
@newsfilterio Verint Announces Q4 and FYE 2021 Results $VRNT $CGNT https://t.co/RknI8ibR0T April 1st 2021, 3:04am |
|
@newsfilterio Verint, Cognyte's Former Parent, Announces Fourth Quarter Financial Results $CGNT $VRNT https://t.co/E4p82EzYgn April 1st 2021, 2:04am |
 |
@StckPro $CGNT $VRNT NEW ARTICLE : Verint, Cognyte's Former Parent, Announces Fourth Quarter Financial Results… https://t.co/pKgf6LfR2N March 31st 2021, 8:03pm |
|
@stock_titan $VRNT $CGNT Verint, Cognyte's Former Parent, Announces Fourth Quarter Financial Results https://t.co/f7ZWAancfG March 31st 2021, 8:03pm |
|
@StckPro $PLTR $CGNT NEW ARTICLE : Cognyte Software: The Value Investor's Palantir https://t.co/Uu8VUvY8vs Get all the lates… https://t.co/k69kuiI9Cn March 28th 2021, 5:03pm |
|
@SeekingAlpha $CGNT - Cognyte Software: The Value Investor's Palantir. https://t.co/9R4kGqy5UO #economy #business #finance March 28th 2021, 5:03pm |
 |
@Ismaila73401178 RT @eddylau26899761: @ALGOV9 spin-off $vrnt was in high 70s until it spun off now its $cgnt opening day #retweet https://t.co/BkwXPw5WD0 March 10th 2021, 5:03pm |
|
@newsfilterio Cognyte Announces Participation in Upcoming Investor Conference $CGNT https://t.co/p7BMSsp8g6 March 9th 2021, 7:03am |
 |
@StockNewsBot2 $CGNT Cognyte Announces Participation in Upcoming Investor Conference March 8th 2021, 1:03pm |
|
@stock_titan $CGNT Cognyte Announces Participation in Upcoming Investor Conference https://t.co/RTmQ1FQbb2 March 8th 2021, 1:03pm |
 |
@JCM_IF Spin-off reciente interesante: $CGNT a buy? by @RobEducated https://t.co/ij84UJRh1p March 6th 2021, 5:03pm |
 |
@stockhoot $CGNT Evercore ISI Group Initiates Coverage On to Outperform : PT $40.00 https://t.co/ENCA2tLHFo March 5th 2021, 11:03am |
 |
@sbwcws Cognyte initiated with an Outperform at Evercore ISI $CGNT March 5th 2021, 10:03am |
 |
@gabrielkaplan @plantmath1 @CNBCFastMoney I wonder what they think about Cognyte Software Ltd $CGNT which is trading at a lower sales multiple. March 4th 2021, 12:03am |
 |
@Bullish_Trader1 $HWAL buy time and $CGNT blast off time!! March 3rd 2021, 8:03pm |
 |
@shlomibatchen @JollibeeTrades $cgnt competitor of $pltr and much less pricey February 19th 2021, 5:02am |
 |
@TradeWithAlerts Large Print $CGNT Size: 206551 Price: 31.26 Time: 930 Amount: $6,456,784.26 February 18th 2021, 2:02pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
